| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/26/2006 | US20060240451 Compositions and methods employing 5' phosphate-dependent nucleic acid exonucleases |
| 10/26/2006 | US20060240448 Cell concentration and lysate clearance using paramagnetic particles |
| 10/26/2006 | US20060240447 Oligonucleotide sequences for the detection of ricin gene and toxin |
| 10/26/2006 | US20060240439 Modified polymerases for improved incorporation of nucleotide analogues |
| 10/26/2006 | US20060240431 Oligonucletide guided analysis of gene expression |
| 10/26/2006 | US20060240425 Genes and polypeptides relating to myeloid leukemia |
| 10/26/2006 | US20060240421 Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy |
| 10/26/2006 | US20060240418 Canine gene microarrays |
| 10/26/2006 | US20060240417 Agent controlling the apoptosis induction by p73 |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240412 Compositions for use in identification of adenoviruses |
| 10/26/2006 | US20060240409 Method for extraction and identification of nucleic acids |
| 10/26/2006 | US20060240407 Detecting the presence of an EV RNA sequence in a sample using enterovirus-specific primers, diagnosing an EV infection in a subject |
| 10/26/2006 | US20060240044 Streptococcal superantigens spe-l and spe-m |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240035 Vmp-like sequences of pathogenic borrelia species and strains |
| 10/26/2006 | US20060240031 T cell receptor cdr3 sequences and methods for detection |
| 10/26/2006 | US20060240025 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression |
| 10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
| 10/26/2006 | US20060240021 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes |
| 10/26/2006 | US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis |
| 10/26/2006 | US20060240003 Humanised antibodies to the epidermal growth factor receptor |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239988 Neuronal regeneration and compound administration methods |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |
| 10/26/2006 | US20060239969 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen |
| 10/26/2006 | US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 10/26/2006 | CA2605068A1 Delivery of sirna by neutral lipid compositions |
| 10/26/2006 | CA2574603A1 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase |
| 10/25/2006 | EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 10/25/2006 | EP1715058A2 Multiplex amplification of short tandem repeat loci |
| 10/25/2006 | EP1714971A2 Directed switch-mediated DNA recombination |
| 10/25/2006 | EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity |
| 10/25/2006 | EP1714969A2 Immunostimulatory nucleic acid molecules |
| 10/25/2006 | EP1713934A1 Tb resistance assay |
| 10/25/2006 | EP1713915A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (MULTIFUNCTIONAL siNA) |
| 10/25/2006 | EP1713825A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 10/25/2006 | EP1543018A4 Gene families associated with liver cancer |
| 10/25/2006 | CN1852980A Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist |
| 10/25/2006 | CN1852917A Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 10/25/2006 | CN1852916A Adrenergic receptor SNP for improved milking characteristics |
| 10/25/2006 | CN1852736A Immunoglobulin chimeric monomer-dimer hybrids |
| 10/25/2006 | CN1852734A Consensus/ancestral immunogens |
| 10/25/2006 | CN1281757C Flavanonol reductase gene of violet wheat and its clone and use |
| 10/25/2006 | CN1281753C Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses |
| 10/25/2006 | CN1281752C Carcinoma of esophagus related gene-2 and use of coding protein thereof |
| 10/25/2006 | CN1281751C DNA mark for inspecting purity of seeds and method thereof |
| 10/25/2006 | CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
| 10/25/2006 | CN1281621C Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point |
| 10/25/2006 | CN1281620C Transfection competent molecules |
| 10/25/2006 | CN1281279C Small interference ribonucleic acid molecule for epidermal growth facor gene and its use |
| 10/24/2006 | US7126044 Plant genes conferring resistance to Citrus tristeza virus |
| 10/24/2006 | US7126042 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 10/24/2006 | US7126041 High efficiency gene targeting in plants |
| 10/24/2006 | US7125982 Microbial production of nuclease resistant DNA, RNA, and oligo mixtures |
| 10/24/2006 | US7125981 Ribosomal DNA sequence for detection of activated sludge bacterial strain; biodegradation; bioremediation |
| 10/24/2006 | US7125980 Diagnostic for organisms key to health of activated sludge wastewater systems |
| 10/24/2006 | US7125979 Upstream control elements of the proopiomelanocortin gene and their use |
| 10/24/2006 | US7125978 Promoter operably linked to a foreign DNA of interest for expression of said foreign DNA; for regulating expression of foreign genes in transgenic plants |
| 10/24/2006 | US7125977 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria |
| 10/24/2006 | US7125976 Method of screening for agents inhibiting chloride intracellular channels |
| 10/24/2006 | US7125975 Derivatized oligonucleotides having improved uptake and other properties |
| 10/24/2006 | US7125974 Viral sequences |
| 10/24/2006 | US7125973 Cell surface display of proteins by recombinant host cells |
| 10/24/2006 | US7125972 Solid support for use in the detect of preferential nucleotide sequences in sample |
| 10/24/2006 | US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus |
| 10/24/2006 | US7125970 Host cells; drug screening; antigrowth agents |
| 10/24/2006 | US7125969 Diagnosis; prognosis; transcription factors |
| 10/24/2006 | US7125947 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization |
| 10/24/2006 | US7125858 Hyaluronic acid in the treatment of cancer |
| 10/24/2006 | US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production |
| 10/24/2006 | US7125712 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 10/24/2006 | US7125705 Expression vector for use as tool in genetic engineering and gene therapy |
| 10/24/2006 | US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack |
| 10/24/2006 | US7125697 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine |
| 10/24/2006 | US7125691 Monitoring nucleotide sequences accumulation; obtain sample, dilute, propagate, monitor accumulation of nucleotide sequences |
| 10/24/2006 | US7125690 Regulatory nucleotide sequence fro use as tools in controlling heterologous/endogenous transcription; transcriptional regulators and bioreactors |
| 10/24/2006 | US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator |
| 10/24/2006 | US7125673 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival |
| 10/24/2006 | US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 10/24/2006 | US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides |
| 10/24/2006 | US7125669 Solid-phase immobilization of proteins and peptides |
| 10/24/2006 | US7125668 Site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials |
| 10/24/2006 | US7125665 Detection of nucleic acid target sequences by electron paramagnetic resonance spectroscopy |
| 10/24/2006 | US7125664 Detection regulatory genes; obtain nucleotide sequences, deposit on grid, mutate preferential gene sequences, monitor and evaluate gene expression |
| 10/24/2006 | US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 10/24/2006 | US7125661 Sequences for the detection of Escherichia coli |
| 10/24/2006 | US7125660 Nucleic acid sensor molecules and methods of using same |
| 10/24/2006 | US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein |
| 10/19/2006 | WO2006110760A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/19/2006 | WO2006110449A2 Agglomeration protein cascades, compositions and methods regarding the same |
| 10/19/2006 | WO2006108358A1 ANTIVIRAL USE OF ARTIFICIAL CpG-CONTAINING SINGLE-STRANDED OLIGODEOXYNUCLEOTIDES IN COMBINATION WITH RIBAVIRIN |
| 10/19/2006 | WO2006074194A3 Engineered phosphite dehydrogenase mutants for nicotinamide cofactor regeneration |
| 10/19/2006 | WO2006071582A3 Methods, compositions, and kits for forming self-complementary polynucleotides |
| 10/19/2006 | WO2006066078A3 Fcϝriib-specific antibodies and methods of use thereof |
| 10/19/2006 | WO2006060649A3 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
| 10/19/2006 | WO2006053201A3 Treatment of cancer by simultaneous inhibition of b-raf and restoration or mimicry of p16 ink4a activity |
| 10/19/2006 | WO2006031843A3 Detection of cancer cells in body fluids |
| 10/19/2006 | WO2006009814A3 Products and methods related to mono-methyl branched-chain fatty acids |
| 10/19/2006 | WO2006007560A3 Targeted protein replacement for the treatment of lysosomal storage disorders |